| Message: | Product Name: Octreotide Acetate
Alias: Sodium Deoxyribose Guarylic Acid,Acetic Octreotide,Octreotide,Sandostatin
CAS: 83150-76-9
MF: C49H66N10O10S2
MW: 1019.28
Purity: 98.0%min
Grade: Pharmaceutical Grade
Appearance: White Powder
Single Impurity (HPLC) : 1.0%max
Amino Acid Composition : ±10% of theoretical
Peptide Content (N%) : ≥80.0%
Water Content(Karl Fischer) : ≤7.0%
Acetate Content(HPIC) : ≤12.0%
Specific Rotation (20/D) : -45.0～-50.0°(c=0.5 95%HAc)
MS (ESI) : Consistent
Mass Balance : 95.0~105.0%
Storage: Closed, below 2 ~ 8℃ preservation
Manufacturer: Hezhong
Usage: octreotide acetate, as an injectable depot formulation for the treatment of growth hormone producing tumors (acromegaly and gigantism).
Description
Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.
|
my account
